338 related articles for article (PubMed ID: 29414119)
21. Tryptophan photo-product FICZ upregulates AHR/MEK/ERK-mediated MMP1 expression: Implications in anti-fibrotic phototherapy.
Murai M; Yamamura K; Hashimoto-Hachiya A; Tsuji G; Furue M; Mitoma C
J Dermatol Sci; 2018 Jul; 91(1):97-103. PubMed ID: 29703420
[TBL] [Abstract][Full Text] [Related]
22. Quinone-mediated induction of cytochrome P450 1A1 in HepG2 cells through increased interaction of aryl hydrocarbon receptor with aryl hydrocarbon receptor nuclear translocator.
Abiko Y; Lin FY; Lee H; Puga A; Kumagai Y
J Toxicol Sci; 2016; 41(6):775-781. PubMed ID: 27853106
[TBL] [Abstract][Full Text] [Related]
23. Nrf2-regulated phase-II detoxification enzymes and phase-III transporters are induced by thyroid hormone in rat liver.
Cornejo P; Vargas R; Videla LA
Biofactors; 2013; 39(5):514-21. PubMed ID: 23554160
[TBL] [Abstract][Full Text] [Related]
24. Modulation of NAD(P)H:quinone oxidoreductase by vanadium in human hepatoma HepG2 cells.
Abdelhamid G; Anwar-Mohamed A; Elmazar MM; El-Kadi AO
Toxicol In Vitro; 2010 Sep; 24(6):1554-61. PubMed ID: 20599494
[TBL] [Abstract][Full Text] [Related]
25. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction.
Ma Q; Kinneer K; Bi Y; Chan JY; Kan YW
Biochem J; 2004 Jan; 377(Pt 1):205-13. PubMed ID: 14510636
[TBL] [Abstract][Full Text] [Related]
26. Enhanced thyroid hormone breakdown in hepatocytes by mutual induction of the constitutive androstane receptor (CAR, NR1I3) and arylhydrocarbon receptor by benzo[a]pyrene and phenobarbital.
Schraplau A; Schewe B; Neuschäfer-Rube F; Ringel S; Neuber C; Kleuser B; Püschel GP
Toxicology; 2015 Feb; 328():21-8. PubMed ID: 25489928
[TBL] [Abstract][Full Text] [Related]
27. Nrf2-inducing anti-oxidation stress response in the rat liver--new beneficial effect of lansoprazole.
Yamashita Y; Ueyama T; Nishi T; Yamamoto Y; Kawakoshi A; Sunami S; Iguchi M; Tamai H; Ueda K; Ito T; Tsuruo Y; Ichinose M
PLoS One; 2014; 9(5):e97419. PubMed ID: 24846271
[TBL] [Abstract][Full Text] [Related]
28. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes.
Andrieux L; Langouët S; Fautrel A; Ezan F; Krauser JA; Savouret JF; Guengerich FP; Baffet G; Guillouzo A
Mol Pharmacol; 2004 Apr; 65(4):934-43. PubMed ID: 15044623
[TBL] [Abstract][Full Text] [Related]
29. Sulindac regulates the aryl hydrocarbon receptor-mediated expression of Phase 1 metabolic enzymes in vivo and in vitro.
Ciolino HP; MacDonald CJ; Memon OS; Bass SE; Yeh GC
Carcinogenesis; 2006 Aug; 27(8):1586-92. PubMed ID: 16531450
[TBL] [Abstract][Full Text] [Related]
30. The glycogen synthase kinase inhibitor 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) is a partial agonist of the aryl hydrocarbon receptor.
Braeuning A; Buchmann A
Drug Metab Dispos; 2009 Aug; 37(8):1576-80. PubMed ID: 19448134
[TBL] [Abstract][Full Text] [Related]
31. Novel roles for AhR and ARNT in the regulation of alcohol dehydrogenases in human hepatic cells.
Attignon EA; Leblanc AF; Le-Grand B; Duval C; Aggerbeck M; Rouach H; Blanc EB
Arch Toxicol; 2017 Jan; 91(1):313-324. PubMed ID: 27055685
[TBL] [Abstract][Full Text] [Related]
32. Curcumin and its derivatives inhibit 2,3,7,8,-tetrachloro-dibenzo-p-dioxin-induced expression of drug metabolizing enzymes through aryl hydrocarbon receptor-mediated pathway.
Nakai R; Fukuda S; Kawase M; Yamashita Y; Ashida H
Biosci Biotechnol Biochem; 2018 Apr; 82(4):616-628. PubMed ID: 29191105
[TBL] [Abstract][Full Text] [Related]
33. The influence of changes in expression of redox-sensitive genes on the development of retinopathy in rats.
Perepechaeva ML; Kolosova NG; Stefanova NA; Fursova AZh; Grishanova AY
Exp Mol Pathol; 2016 Aug; 101(1):124-32. PubMed ID: 27466007
[TBL] [Abstract][Full Text] [Related]
34. Renal toxicity through AhR, PXR, and Nrf2 signaling pathway activation of ochratoxin A-induced oxidative stress in kidney cells.
Lee HJ; Pyo MC; Shin HS; Ryu D; Lee KW
Food Chem Toxicol; 2018 Dec; 122():59-68. PubMed ID: 30291945
[TBL] [Abstract][Full Text] [Related]
35. In vitro assessment of drug-drug interaction potential of boceprevir associated with drug metabolizing enzymes and transporters.
Chu X; Cai X; Cui D; Tang C; Ghosal A; Chan G; Green MD; Kuo Y; Liang Y; Maciolek CM; Palamanda J; Evers R; Prueksaritanont T
Drug Metab Dispos; 2013 Mar; 41(3):668-81. PubMed ID: 23293300
[TBL] [Abstract][Full Text] [Related]
36. Structural influence of isothiocyanates on expression of cytochrome P450, phase II enzymes, and activation of Nrf2 in primary rat hepatocytes.
La Marca M; Beffy P; Della Croce C; Gervasi PG; Iori R; Puccinelli E; Longo V
Food Chem Toxicol; 2012 Aug; 50(8):2822-30. PubMed ID: 22664424
[TBL] [Abstract][Full Text] [Related]
37. Shikonin Suppresses Lymphangiogenesis via NF-κB/HIF-1α Axis Inhibition.
Prangsaengtong O; Jantaree P; Lirdprapamongkol K; Svasti J; Koizumi K
Biol Pharm Bull; 2018; 41(11):1659-1666. PubMed ID: 30381665
[TBL] [Abstract][Full Text] [Related]
38. Alterations in hepatic mRNA expression of phase II enzymes and xenobiotic transporters after targeted disruption of hepatocyte nuclear factor 4 alpha.
Lu H; Gonzalez FJ; Klaassen C
Toxicol Sci; 2010 Dec; 118(2):380-90. PubMed ID: 20935164
[TBL] [Abstract][Full Text] [Related]
39. Short-term calorie restriction feminizes the mRNA profiles of drug metabolizing enzymes and transporters in livers of mice.
Fu ZD; Klaassen CD
Toxicol Appl Pharmacol; 2014 Jan; 274(1):137-46. PubMed ID: 24240088
[TBL] [Abstract][Full Text] [Related]
40. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
